AAAAAA

   
Results: 1-5 |
Results: 5

Authors: PAWLIK CA HOUGHTON PJ STEWART CF CHESHIRE PJ RICHMOND LB DANKS MK
Citation: Ca. Pawlik et al., EFFECTIVE SCHEDULES OF EXPOSURE OF MEDULLOBLASTOMA AND RHABDOMYOSARCOMA XENOGRAFTS TO TOPOTECAN CORRELATE WITH IN-VITRO ASSAYS, Clinical cancer research, 4(8), 1998, pp. 1995-2002

Authors: PAWLIK CA ISRAEL M SWEATMAN TW LOTHSTEIN L
Citation: Ca. Pawlik et al., CELLULAR-RESISTANCE AGAINST THE NOVEL HYBRID ANTHRACYCLINE N-(2-CHLOROETHYL)-N-NITROSOUREIDODAUNORUBICIN (AD-312) IS MEDIATED BY COMBINED ALTERED TOPOISOMERASE-II AND O-6-METHYLGUANINE-DNA METHYLTRANSFERASE ACTIVITIES, Oncology research, 10(4), 1998, pp. 209-217

Authors: POTTER PM PAWLIK CA MORTON CL NAEVE CW DANKS MK
Citation: Pm. Potter et al., ISOLATION AND PARTIAL CHARACTERIZATION OF A CDNA-ENCODING A RABBIT LIVER CARBOXYLESTERASE THAT ACTIVATES THE PRODRUG IRINOTECAN (CPT-11), Cancer research, 58(12), 1998, pp. 2646-2651

Authors: DANKS MK MORTON CL PAWLIK CA POTTER PM
Citation: Mk. Danks et al., OVEREXPRESSION OF A RABBIT LIVER CARBOXYLESTERASE SENSITIZES HUMAN TUMOR-CELLS TO CPT-11, Cancer research, 58(1), 1998, pp. 20-22

Authors: DANKS MK PAWLIK CA WHIPPLE DO WOLVERTON JS
Citation: Mk. Danks et al., INTERMITTENT EXPOSURE OF MEDULLOBLASTOMA CELLS TO TOPOTECAN PRODUCES GROWTH-INHIBITION EQUIVALENT TO CONTINUOUS EXPOSURE, Clinical cancer research, 3(10), 1997, pp. 1731-1738
Risultati: 1-5 |